Resultados de búsqueda - John‐Paul Westwood
- Mostrando 1 - 11 Resultados de 11
-
1
-
2
-
3
-
4
Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens por John‐Paul Westwood, Mari Thomas, Ferras Alwan, Vickie McDonald, Sylvia Benjamin, Will Lester, Gillian Lowe, Tina Dutt, Quentin A. Hill, Marie Scully
Publicado 2017Artigo -
5
-
6
A British Society for Haematology Guideline: Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies por Marie Scully, R. Rayment, Amanda Clark, John‐Paul Westwood, Tanya Cranfield, Richard Gooding, Catherine Bagot, A. E. Taylor, Vinoth Sankar, Daniel P. Gale, Tina Dutt, J McIntyre, Will Lester
Publicado 2023Artigo -
7
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura por Flora Peyvandi, Marie Scully, Johanna A. Kremer Hovinga, Spero Cataland, Paul Knöbl, Haifeng Wu, Andrea Artoni, John‐Paul Westwood, Magnus Mansouri Taleghani, Bernd Jilma, Filip Callewaert, Hans Ulrichts, Christian Duby, Dominique Tersago
Publicado 2016Artigo -
8
Redefining outcomes in immune TTP: an international working group consensus report por Adam Cuker, Spero R. Cataland, Paul Coppo, Javier de la Rubia, Kenneth D. Friedman, James N. George, Paul Knoebl, Johanna A. Kremer Hovinga, Bernhard Lämmle, Masanori Matsumoto, Katerina Pavenski, Flora Peyvandi, Kazuya Sakai, Ravi Sarode, Mari R. Thomas, Yoshiaki Tomiyama, Agnès Veyradier, John‐Paul Westwood, Marie Scully
Publicado 2021Artigo -
9
Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies por Marie Scully, Spero R. Cataland, Paul Coppo, Javier de la Rubia, Kenneth D. Friedman, Johanna A. Kremer Hovinga, Bernhard Lämmle, Masanori Matsumoto, Katerina Pavenski, J. Evan Sadler, Ravi Sarode, Haifeng Wu, Daniel P. Gale, Yoshihiro Fujimura, Vickie McDonald, Flora Peyvandi, I. Scharrer, Agnès Veyradier, John‐Paul Westwood
Publicado 2016Artigo -
10
Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura por Ferras Alwan, Chiara Vendramin, Karen Vanhoorelbeke, Katy Langley, Vickie McDonald, Steve Austin, Amanda Clark, Will Lester, Richard Gooding, Tina Biss, Tina Dutt, Nichola Cooper, Oliver Chapman, Tanya Cranfield, K. Douglas, Henry G. Watson, Joost J. van Veen, Keith Sibson, William Thomas, Lynn Manson, Quentin A. Hill, Sylvia Benjamin, Debra Ellis, John‐Paul Westwood, Mari Thomas, Marie Scully
Publicado 2017Artigo -
11
Characterization and treatment of congenital thrombotic thrombocytopenic purpura por Ferras Alwan, Chiara Vendramin, Ri Liesner, Amanda Clark, Will Lester, Tina Dutt, William Thomas, Richard Gooding, Tina Biss, Henry G. Watson, Nichola Cooper, Rachel Rayment, Tanya Cranfield, Joost J. van Veen, Quentin A. Hill, Sarah Davis, Jayashree Motwani, Neha Bhatnagar, Nicole Priddee, Marianna Dávid, Maeve P. Crowley, Jayanthi Alamelu, Hamish Lyall, John‐Paul Westwood, Mari Thomas, Marie Scully
Publicado 2019Revisão
Herramientas de búsqueda:
Materias Relacionadas
Medicine
Internal medicine
Platelet
Thrombotic thrombocytopenic purpura
ADAMTS13
Gastroenterology
Immunology
Antibody
Exacerbation
Intensive care medicine
Pathology
Pediatrics
Rituximab
Surgery
Von Willebrand factor
Adverse effect
Alternative medicine
Antigen
Aspirin
Astrobiology
Biochemistry
Biology
Bortezomib
Chemistry
Clinical trial
Cohort
Complement factor B
Complement system
Compound heterozygosity
Computer science